Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
39
BAYRY Quote, Financials, Valuation and Earnings
Last price:
$12.30
Seasonality move
:
3.55%
Day range:
$12.21 - $12.42
52-week range:
$5.30 - $14.85
Dividend yield:
0.25%
P/E ratio:
--
P/S ratio:
0.96x
P/B ratio:
1.39x
Volume:
1.6M
Avg. volume:
1.5M
1-year change:
103.81%
Market cap:
$48.4B
Revenue:
$50.4B
EPS (TTM):
-$0.09
Analysts' Opinion
-
Consensus RatingBayer AG has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $14.89, Bayer AG has an estimated upside of 20.94% from its current price of $12.31.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $12.35 representing -0.33% downside risk from its current price of $12.31.
Fair Value
-
According to the consensus of 3 analysts, Bayer AG has 20.94% upside to fair value with a price target of $14.89 per share.
BAYRY vs. S&P 500
-
Over the past 5 trading days, Bayer AG has underperformed the S&P 500 by -7.3% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Bayer AG does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bayer AG has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Bayer AG reported revenues of $11.3B.
Earnings Growth
-
Bayer AG has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Bayer AG reported earnings per share of -$0.29.
Enterprise value:
88.2B
EV / Invested capital:
--
Price / LTM sales:
0.96x
EV / EBIT:
14.23x
EV / Revenue:
1.75x
PEG ratio (5yr expected):
-0.05x
EV / Free cash flow:
32.75x
Price / Operating cash flow:
17.97x
Enterprise value / EBITDA:
9.01x
Gross Profit (TTM):
$28.4B
Return On Assets:
-0.26%
Net Income Margin (TTM):
-0.62%
Return On Equity:
-0.91%
Return On Invested Capital:
-0.4%
Operating Margin:
5.81%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $50.9B | $50.6B | $50.4B | $11B | $11.3B | |
| Gross Profit | $29.6B | $28.9B | $28.4B | $5.4B | $6.3B | |
| Operating Income | $7.2B | $7.5B | $6.2B | -$153.8M | $655.6M | |
| EBITDA | $11.2B | $12B | $9.8B | $927.2M | $1.8B | |
| Diluted EPS | -$1.03 | -$0.26 | -$0.09 | -$1.17 | -$0.29 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $37B | $37.6B | $39.7B | $37B | $38.6B | |
| Total Assets | $135.1B | $128.3B | $124.1B | $119.4B | $122.4B | |
| Current Liabilities | $33.3B | $32.5B | $35B | $28B | $34B | |
| Total Liabilities | $98.9B | $87.7B | $88.6B | $85.1B | $87.5B | |
| Total Equity | $36.2B | $40.6B | $35.5B | $34.3B | $34.9B | |
| Total Debt | $42.9B | $38.7B | $37.2B | $40.9B | $38.4B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $1.5B | $7.3B | $5.8B | $1.9B | $1.6B | |
| Cash From Investing | $69.2M | -$3.2B | -$2.7B | $3.9B | -$1.3B | |
| Cash From Financing | $1.3B | -$6.2B | -$1.4B | -$4.9B | $1.2B | |
| Free Cash Flow | -$1.8B | $4.4B | $2.7B | $1.2B | $616.1M | |
BAYRY
Sector
Market Cap
$48.4B
$25.8M
Price % of 52-Week High
82.9%
50.24%
Dividend Yield
0.25%
0%
Shareholder Yield
2.47%
-1.64%
1-Year Price Total Return
103.81%
-18.88%
Beta (5-Year)
0.677
0.496
Dividend yield:
0.25%
Annualized payout:
$0.03
Payout ratio:
3.11%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$12.94
200-day SMA
Buy
Level
$9.05
Bollinger Bands (100)
Buy
Level
8.12 - 12.5
Chaikin Money Flow
Buy
Level
241.7M
20-day SMA
Sell
Level
$13.24
Relative Strength Index (RSI14)
Sell
Level
42.59
ADX Line
Buy
Level
40.49
Williams %R
Buy
Level
-96.2851
50-day SMA
Buy
Level
$12.21
MACD (12, 26)
Buy
Level
0.06
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Sell
Level
-6.3M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.8427)
Sell
CA Score
(Annual)
Level (-1.2046)
Buy
Beneish M-Score
(Annual)
Level (-2.8979)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (0.1753)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.
Stock Forecast FAQ
In the current month, BAYRY has received 1 Buy ratings 2 Hold ratings, and 0 Sell ratings. The BAYRY average analyst price target in the past 3 months is $14.89.
-
Where Will Bayer AG Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bayer AG share price will rise to $14.89 per share over the next 12 months.
-
What Do Analysts Say About Bayer AG?
Analysts are divided on their view about Bayer AG share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bayer AG is a Sell and believe this share price will drop from its current level to $12.35.
-
What Is Bayer AG's Price Target?
The price target for Bayer AG over the next 1-year time period is forecast to be $14.89 according to 3 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is BAYRY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bayer AG is a Hold. 2 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of BAYRY?
You can purchase shares of Bayer AG via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bayer AG shares.
-
What Is The Bayer AG Share Price Today?
Bayer AG was last trading at $12.30 per share. This represents the most recent stock quote for Bayer AG. Yesterday, Bayer AG closed at $12.31 per share.
-
How To Buy Bayer AG Stock Online?
In order to purchase Bayer AG stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get BAYRY Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BAYRY
Sector
P/E ratio
--
23.44x
PEG ratio
-0.05x
-0.01x
P/B ratio
1.39x
1.81x
Price / LTM sales
0.96x
1.56x
Growth Metrics
BAYRY
Sector
Revenue growth
3.09%
3.27%
Earnings growth
75.51%
9.66%
Revenue (5-year growth)
0.68%
6.43%
Earnings forecast
$0.16
-$0.20
Profitability
BAYRY
Sector
Profitability FY 2024
$27.4B
$2.3M
Return on invested capital
-0.4%
-33.49%
Return on assets
-0.26%
-29.74%
Return on equity
-0.91%
-39.33%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Mar
4
Estimated Next Earnings Date
Feb
11
Balance Sheet
BAYRY
Sector
Total cash
$6.9B
$24.2M
Short term investments
$2B
$23.8M
Total assets
$122B
$71.1M
Long term debt
$38.4B
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
50
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
37
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 28x
Alerts
Buy
59
SEZL alert for Feb 27
Sezzle, Inc. [SEZL] is down 13.92% over the past day.
Buy
83
GCT alert for Feb 27
GigaCloud Technology, Inc. [GCT] is down 5.87% over the past day.
Buy
62
LMAT alert for Feb 27
LeMaitre Vascular, Inc. [LMAT] is down 4.76% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
